ISSC Q2 2026 Earnings Transcript

Innovative Aerosystems reported Q2 revenue of $22.4 million, up 2% year over year, as 50% growth in commercial aerospace and business aviation offset a $7 million decline in F-16 revenues. Gross profit rose to $11.4 million and backlog increased to about $87 million, while free cash flow improved sharply to $7.7 million in the first half from $1.3 million a year ago. Management guided Q3 revenue to $24 million-$26 million and said full-year organic growth should be essentially flat, but highlighted three acquisitions expected to add $10 million in annual revenue and a normalized F-16 run rate of $3 million-$5 million per quarter.

Analysis

The important second-order read-through is that ISSC is transitioning from a lumpy defense-rework story into a broader avionics consolidator with a more repeatable aftermarket mix. That is strategically attractive because the newly acquired autopilot and cockpit assets should reduce dependence on any single program, but near-term integration will keep reported earnings below cash earnings as amortization and R&D step up. The market is likely still underappreciating how much of the incremental revenue from the deals is higher-quality recurring retrofit demand rather than pure one-time product transfers.

For LMT, the signal is mildly constructive: ISSC’s comments imply the F-16 supply chain is back to normalized throughput, which reduces execution risk around sustainment and upgrades. The more interesting implication is competitive, not contractual — if ISSC becomes the go-to aggregator for legacy cockpit subsystems, it can pressure smaller niche suppliers that previously benefited from fragmented OEM divestitures. HON and MOG.B are the latent losers here because ISSC is effectively extracting value from their portfolio pruning and turning it into a more integrated competing platform.

The main risk is that consensus may be too focused on revenue growth and not enough on margin dilution as military mix rebuilds and acquisition-related integration costs persist over the next 2-4 quarters. The upside catalyst is clear: if the company can convert the active pipeline into another 1-2 small-to-mid product line deals, leverage should stay manageable while free cash flow funds expansion. But if defense procurement timing slips or the commercial aftermarket normalizes, the stock could de-rate quickly because the current setup is still dependent on “good news” compounding quarter to quarter.

Key Decisions for Investors

• Long ISSC on a 3-6 month horizon into any pullback from acquisition fatigue; the setup is attractive if management can keep free cash flow positive while adding assets, but size modestly because earnings quality is still noisy.
• Pair trade: long ISSC / short a basket of legacy avionics suppliers exposed to divestitures (monitor HON and MOG.B as conceptual shorts or relative-value underweights); thesis is ISSC is monetizing their portfolio simplification better than they can.
• Buy LMT on weakness if the market misreads this as a pure defense demand data point; this looks more like program normalization than a new order-cycle acceleration, so the stock benefits if execution fear fades.
• Avoid chasing the move in the next 1-2 weeks; the better entry is after the market digests the likely margin reset commentary as the acquisition mix rolls into reported results.
• For aggressive accounts: consider an ISSC call spread over the next two quarters if liquidity is sufficient, betting that another acquisition or backlog step-up arrives before the market fully capitalizes the runway.